Summit Financial Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Summit Financial Strategies’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,448	Closed	-$240K	–	44
2016 Q3	$240K	Buy	4,448 +360	+9%	+$23.1K	0.17%	34
2016 Q2	$301K	Hold	4,088	–	–	0.22%	29
2016 Q1	$261K	Hold	4,088	–	–	0.19%	34
2015 Q4	$281K	Sell	4,088 -730	-15%	-$48.2K	0.22%	36
2015 Q3	$285K	Sell	4,818 -8	-0.2%	-$508	0.24%	34
2015 Q2	$321K	Buy	4,826 +8	+0.2%	+$527	0.25%	33
2015 Q1	$311K	Hold	4,818	–	–	0.25%	28
2014 Q4	$284K	Buy	+4,818	New	+$272K	0.23%	32

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Summit Financial Strategies's BMY Position: Q4 2016 in Review

Summit Financial Strategies sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 4,448 shares — an estimated $240K sold.

Summit Financial Strategies first reported a position in BMY in Q4 2014 and held it in 8 quarters. The position peaked at $321K in Q2 2015. 1,602 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

Summit Financial Strategies reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
Summit Financial Strategies sold 4,448 Bristol-Myers Squibb shares in Q4 2016, an estimated $240K.
Summit Financial Strategies first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 8 quarters.
Summit Financial Strategies's Bristol-Myers Squibb position peaked at $321K in Q2 2015.
1,602 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Summit Financial Strategies's 13F filing for Q4 2016, filed 8 Feb 2017.